<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Awaiting price reaction for this filing.
Soni Medicare Ltd has submitted its initial disclosure to BSE as required under SEBI's Large Corporate Framework circulars dated October 2023, August 2021, and November 2018. The company has confirmed that it does NOT fall under the 'Large Corporate' category based on the criteria laid out in these SEBI circulars. As a result, the provisions of the Large Corporate framework (which relate to mandatory borrowing/raising of funds through debt markets) are stated as not applicable to Soni Medicare. The disclosure is signed by Managing Director Bimal Roy Soni (DIN: 00716246) and dated April 17, 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock. It simply confirms the company is small enough to be exempt from the Large Corporate borrowing requirements under SEBI rules.